UCL is a radically different university. Founded in 1826 in the heart of London, we were the first university in England to welcome students of any religion and the first to admit women on equal terms with men. That pioneering and inclusive spirit continues to shape our institution today.
With over 51,000 students and 18,000 staff from more than 150 countries, UCL is consistently ranked among the top ten universities globally. We champion innovation, creativity, and cross-disciplinary collaboration in both teaching and research, and our community is tackling some of the most pressing challenges of our time – from advancing dementia and cancer research, to shaping global policy, and ensuring the ethical development of artificial intelligence.
UCL is now seeking to appoint an outstanding Director to lead the Institute of Infection, Immunity and Transplantation, one of our most vibrant, research‑intensive, and internationally influential academic communities within the Faculty of Medical Sciences (FMS). Reporting to the Executive Dean, the Director will provide strategic leadership and work closely with colleagues across FMS to advance the Institute’s scientific ambitions, strengthen its clinical and translational impact, and contribute to the delivery of UCL’s strategic objectives in alignment with the UCL Strategic Plan 2022–2027.
Candidates will need to demonstrate experience of academic leadership including the effective management of staff and resources, alongside an international reputation in a field of research relevant to the Institute. The capacity to develop and motivate staff and develop strong internal and external relationships will need to be coupled with a results-driven approach and the ability to be decisive when appropriate.
How to Apply:
Applications should consist of a CV accompanied by a cover letter addressing the criteria in the person specification and motivation for applying. Completed applications should be submitted electronically to [email protected]
The deadline for receipt of applications is noon on Friday 10th April 2026.
The final interviews will take place in June 2026.